Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes.
Parkinson's disease
astrocytes
clusterin
hiPSC
α-synuclein
Journal
Glia
ISSN: 1098-1136
Titre abrégé: Glia
Pays: United States
ID NLM: 8806785
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
12
06
2020
revised:
23
09
2020
accepted:
29
09
2020
pubmed:
13
10
2020
medline:
14
1
2022
entrez:
12
10
2020
Statut:
ppublish
Résumé
The progressive neuropathological damage seen in Parkinson's disease (PD) is thought to be related to the spreading of aggregated forms of α-synuclein. Clearance of extracellular α-synuclein released by degenerating neurons may be therefore a key mechanism to control the concentration of α-synuclein in the extracellular space. Several molecular chaperones control misfolded protein accumulation in the extracellular compartment. Among these, clusterin, a glycoprotein associated with Alzheimer's disease, binds α-synuclein aggregated species and is present in Lewy bodies, intraneuronal aggregates mainly composed by fibrillary α-synuclein. In this study, using murine primary astrocytes with clusterin genetic deletion, human-induced pluripotent stem cell (iPSC)-derived astrocytes with clusterin silencing and two animal models relevant for PD we explore how clusterin affects the clearance of α-synuclein aggregates by astrocytes. Our findings showed that astrocytes take up α-synuclein preformed fibrils (pffs) through dynamin-dependent endocytosis and that clusterin levels are modulated in the culture media of cells upon α-synuclein pffs exposure. Specifically, we found that clusterin interacts with α-synuclein pffs in the extracellular compartment and the clusterin/α-synuclein complex can be internalized by astrocytes. Mechanistically, using clusterin knock-out primary astrocytes and clusterin knock-down hiPSC-derived astrocytes we observed that clusterin limits the uptake of α-synuclein pffs by cells. Interestingly, we detected increased levels of clusterin in the adeno-associated virus- and the α-synuclein pffs- injected mouse model, suggesting a crucial role of this chaperone in the pathogenesis of PD. Overall, our observations indicate that clusterin can limit the uptake of extracellular α-synuclein aggregates by astrocytes and, hence, contribute to the spreading of Parkinson pathology.
Identifiants
pubmed: 33045109
doi: 10.1002/glia.23920
pmc: PMC7821254
doi:
Substances chimiques
Clusterin
0
alpha-Synuclein
0
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
681-696Informations de copyright
© 2020 The Authors. GLIA published by Wiley Periodicals LLC.
Références
Front Neurosci. 2019 Feb 28;13:164
pubmed: 30872998
J Neurochem. 2016 Oct;139 Suppl 1:131-155
pubmed: 27018978
Science. 2012 Nov 16;338(6109):949-53
pubmed: 23161999
Oncogene. 2009 Dec 10;28(49):4344-52
pubmed: 19784068
Stem Cell Reports. 2019 Feb 12;12(2):213-229
pubmed: 30639209
Acta Neuropathol. 2017 Nov;134(5):789-808
pubmed: 28725967
Glia. 2013 Mar;61(3):349-60
pubmed: 23108585
J Neurochem. 1996 Sep;67(3):1324-7
pubmed: 8752142
Prog Brain Res. 2010;184:89-111
pubmed: 20887871
Stem Cell Reports. 2018 Oct 9;11(4):998-1008
pubmed: 30269954
Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3213-9
pubmed: 22315428
Glia. 2021 Mar;69(3):681-696
pubmed: 33045109
Glia. 2014 Apr;62(4):493-503
pubmed: 24446231
Stem Cells Transl Med. 2013 Nov;2(11):862-70
pubmed: 24113065
Nature. 2011 Jul 20;475(7356):324-32
pubmed: 21776078
Dev Cell. 2006 Jun;10(6):839-50
pubmed: 16740485
Trends Biochem Sci. 2000 Mar;25(3):95-8
pubmed: 10694874
J Neurochem. 2017 Feb;140(4):662-678
pubmed: 27424880
J Neuroinflammation. 2015 Dec 09;12:230
pubmed: 26646749
J Biol Chem. 1997 Jul 25;272(30):18644-9
pubmed: 9228033
J Biol Chem. 2010 Mar 19;285(12):9262-72
pubmed: 20071342
Biochim Biophys Acta. 2015 Jan;1849(1):44-54
pubmed: 25464035
Science. 2016 Sep 30;353(6307):
pubmed: 27708076
Brain Struct Funct. 2012 Apr;217(2):591-612
pubmed: 21935672
BMC Neurosci. 2015 Sep 07;16:57
pubmed: 26346361
Neurobiol Dis. 2019 Sep;129:67-78
pubmed: 31102768
EMBO Rep. 2005 Dec;6(12):1131-6
pubmed: 16319958
Acta Neuropathol. 2018 Oct;136(4):621-639
pubmed: 30046897
J Natl Cancer Inst. 2009 May 6;101(9):663-77
pubmed: 19401549
Nature. 1997 Aug 28;388(6645):839-40
pubmed: 9278044
Neuropathol Appl Neurobiol. 2016 Feb;42(1):33-50
pubmed: 26662475
Mol Cell Neurosci. 2017 Jul;82:143-156
pubmed: 28450268
Glia. 2006 Nov 15;54(7):716-25
pubmed: 17006900
Neurobiol Dis. 2018 Jan;109(Pt B):219-225
pubmed: 28323023
J Biol Chem. 2018 Mar 23;293(12):4486-4497
pubmed: 29382725
Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4229-34
pubmed: 8633046
Oxid Med Cell Longev. 2010 Jul-Aug;3(4):283-7
pubmed: 20972375
J Comp Neurol. 1994 Jan 15;339(3):387-400
pubmed: 8132868
J Neuropathol Exp Neurol. 1996 Mar;55(3):259-72
pubmed: 8786384
Neurobiol Dis. 2012 Mar;45(3):939-53
pubmed: 22182688
FASEB J. 2007 Aug;21(10):2312-22
pubmed: 17412999
Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10843-8
pubmed: 12145324
Neuron. 2004 Jan 22;41(2):193-202
pubmed: 14741101
Sci Rep. 2017 Aug 21;7(1):9008
pubmed: 28827536
Trends Neurosci. 2017 Jun;40(6):358-370
pubmed: 28527591
Mol Biosyst. 2008 Jan;4(1):42-52
pubmed: 18075673
Acta Neuropathol Commun. 2017 Nov 7;5(1):81
pubmed: 29115989
Acta Neuropathol. 2000 Jan;99(1):14-20
pubmed: 10651022
Neurobiol Dis. 2020 Feb;134:104647
pubmed: 31669751
Glia. 2010 Aug;58(10):1235-46
pubmed: 20544859
Mol Neurobiol. 2018 Feb;55(2):1054-1067
pubmed: 28092083
Biomol Ther (Seoul). 2018 Jul 1;26(4):350-357
pubmed: 29316776
Neurobiol Dis. 2019 Sep;129:1-12
pubmed: 31051233
Cell Mol Neurobiol. 2019 Mar;39(2):161-168
pubmed: 30637614
Lancet. 2009 Jun 13;373(9680):2055-66
pubmed: 19524782
Neurobiol Dis. 2019 Oct;130:104525
pubmed: 31276792
J Neuroimmunol. 1995 Apr;58(1):101-10
pubmed: 7730444
Biophys J. 2006 May 1;90(9):3134-45
pubmed: 16603504
Cell Rep. 2018 Jun 19;23(12):3492-3500
pubmed: 29924993
BMC Neurosci. 2018 Jan 25;19(1):2
pubmed: 29370749
Biomolecules. 2015 Apr 14;5(2):435-71
pubmed: 25874605
Acta Neuropathol. 2007 Sep;114(3):231-41
pubmed: 17576580